288 related articles for article (PubMed ID: 31277247)
1. Possible Involvement of Intracellular Calcium-Independent Phospholipase A
Christerson U; Keita ÅV; Winberg ME; Söderholm JD; Gustafson-Svärd C
Cells; 2019 Jul; 8(7):. PubMed ID: 31277247
[TBL] [Abstract][Full Text] [Related]
2. Secreted phospholipase A2 and mast cells.
Murakami M; Taketomi Y
Allergol Int; 2015 Jan; 64(1):4-10. PubMed ID: 25572553
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between cytosolic phospholipase A2 alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells: sPLA2 regulates cPLA2 alpha activity that is responsible for arachidonic acid release.
Han WK; Sapirstein A; Hung CC; Alessandrini A; Bonventre JV
J Biol Chem; 2003 Jun; 278(26):24153-63. PubMed ID: 12676927
[TBL] [Abstract][Full Text] [Related]
4. The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2.
Murakami M; Shimbara S; Kambe T; Kuwata H; Winstead MV; Tischfield JA; Kudo I
J Biol Chem; 1998 Jun; 273(23):14411-23. PubMed ID: 9603953
[TBL] [Abstract][Full Text] [Related]
5. Presence of group IIa secretory phospholipase A2 in mast cells and macrophages in normal human ileal submucosa and in Crohn's disease.
Lilja I; Gustafson-Svärd C; Franzeń L; Sjödahl R; Andersen S; Johansen B
Clin Chem Lab Med; 2000 Dec; 38(12):1231-6. PubMed ID: 11205686
[TBL] [Abstract][Full Text] [Related]
6. Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions.
Tada K; Murakami M; Kambe T; Kudo I
J Immunol; 1998 Nov; 161(9):5008-15. PubMed ID: 9794438
[TBL] [Abstract][Full Text] [Related]
7. Bromoenol lactone, an inhibitor of Group V1A calcium-independent phospholipase A2 inhibits antigen-stimulated mast cell exocytosis without blocking Ca2+ influx.
Fensome-Green A; Stannard N; Li M; Bolsover S; Cockcroft S
Cell Calcium; 2007 Feb; 41(2):145-53. PubMed ID: 16854462
[TBL] [Abstract][Full Text] [Related]
8. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.
Fonteh AN; Atsumi G; LaPorte T; Chilton FH
J Immunol; 2000 Sep; 165(5):2773-82. PubMed ID: 10946309
[TBL] [Abstract][Full Text] [Related]
9. A β-Glucan-Based Dietary Fiber Reduces Mast Cell-Induced Hyperpermeability in Ileum From Patients With Crohn's Disease and Control Subjects.
Ganda Mall JP; Casado-Bedmar M; Winberg ME; Brummer RJ; Schoultz I; Keita ÅV
Inflamm Bowel Dis; 2017 Dec; 24(1):166-178. PubMed ID: 29272475
[TBL] [Abstract][Full Text] [Related]
10. Progesterone-induced Acrosome Exocytosis Requires Sequential Involvement of Calcium-independent Phospholipase A2β (iPLA2β) and Group X Secreted Phospholipase A2 (sPLA2).
Abi Nahed R; Martinez G; Escoffier J; Yassine S; Karaouzène T; Hograindleur JP; Turk J; Kokotos G; Ray PF; Bottari S; Lambeau G; Hennebicq S; Arnoult C
J Biol Chem; 2016 Feb; 291(6):3076-89. PubMed ID: 26655718
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.
Rönkkö S; Rekonen P; Kaarniranta K; Puustjarvi T; Teräsvirta M; Uusitalo H
Mol Vis; 2007 Mar; 13():408-17. PubMed ID: 17417602
[TBL] [Abstract][Full Text] [Related]
12. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
[TBL] [Abstract][Full Text] [Related]
13. Redundant and segregated functions of granule-associated heparin-binding group II subfamily of secretory phospholipases A2 in the regulation of degranulation and prostaglandin D2 synthesis in mast cells.
Enomoto A; Murakami M; Valentin E; Lambeau G; Gelb MH; Kudo I
J Immunol; 2000 Oct; 165(7):4007-14. PubMed ID: 11034411
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.
Lilja I; Smedh K; Olaison G; Sjödahl R; Tagesson C; Gustafson-Svärd C
Gut; 1995 Sep; 37(3):380-5. PubMed ID: 7590434
[TBL] [Abstract][Full Text] [Related]
15. Mast Cell-Specific Deletion of Group III Secreted Phospholipase A
Taketomi Y; Endo Y; Higashi T; Murase R; Ono T; Taya C; Kobayashi T; Murakami M
Cells; 2021 Jul; 10(7):. PubMed ID: 34359862
[TBL] [Abstract][Full Text] [Related]
16. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues.
Masuda S; Murakami M; Ishikawa Y; Ishii T; Kudo I
Biochim Biophys Acta; 2005 Oct; 1736(3):200-10. PubMed ID: 16188494
[TBL] [Abstract][Full Text] [Related]
17. Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's disease.
van Dullemen HM; Wolbink GJ; Wever PC; van der Poll T; Hack CE; Tytgat GN; van Deventer SJ
Scand J Gastroenterol; 1998 Oct; 33(10):1094-8. PubMed ID: 9829366
[TBL] [Abstract][Full Text] [Related]
18. Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes.
Ali T; Kokotos G; Magrioti V; Bone RN; Mobley JA; Hancock W; Ramanadham S
PLoS One; 2013; 8(8):e71748. PubMed ID: 23977134
[TBL] [Abstract][Full Text] [Related]
19. Increased phospholipase A2 activity of Ileal mucosa in Crohn's disease.
Olaison G; Sjödahl R; Tagesson C
Digestion; 1988; 41(3):136-41. PubMed ID: 3224765
[TBL] [Abstract][Full Text] [Related]
20. Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages.
Triggiani M; Granata F; Oriente A; De Marino V; Gentile M; Calabrese C; Palumbo C; Marone G
J Immunol; 2000 May; 164(9):4908-15. PubMed ID: 10779801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
